Showing 1–5 of 5 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Eskild Petersen, Martin Rao, Giuseppe Ippolito, Gina Gualano, Jeremiah Chakaya, et al.
…uch-needed resources to find, diagnose and treat 40 million adults and children who will be affected by TB by 2022, and to conduct research on new diagnostics, treatments and vaccines required to achieve global TB control (Tiberi et al., 2018Tiberi S. Petersen E. Maeurer M. Ntoum…
Ahmed M, Farris E, Swanson RV, Das S, Yang Y, et al.
…o affect other sites (extrapulmonary TB). The only licensed vaccine Mycobacterium bovis bacillus Calmette-Guerin (BCG) protects infants and young children but exhibits variable efficacy in protecting against adult pulmonary TB. Poor compliance and prolonged treatment regimens ass…
Cynthia Bin Eng Chee, David S.C. Hui
… continue to be important. The availability of pneumococcal vaccines and multiplex polymerase chain reactions (PCR) has led to a decreasing incidence of pneumococcal pneumonia and detection of more viral aetiologies in CAP. In recent years, rapid and automated molecular tests bas…
SushantSatish Mane
… extrapulmonary TB cases is more in children as compared to adults. Despite such high figures, the estimated detection gap for TB in children is around 56%. This may be due to factors such as a lack of knowledge about presumptive TB among health-care providers, delays in seeking …
Marimani M, AlOmar SY, Aldahmash B, Ahmad A, Stacey S, et al.
…nates into other host organs. The Bacillus Calmette-Guérin (BCG) vaccine is employed to provide immune protection against TB; however, its efficacy is dependent on the age, immune status and geographic location of vaccinated individuals. Advanced diagnostic approaches such as Gen…